Literature DB >> 22705584

Changes in mitochondrial DNA alter expression of nuclear encoded genes associated with tumorigenesis.

Jana Jandova1, Jaroslav Janda, James E Sligh.   

Abstract

We previously reported the presence of a mtDNA mutation hotspot in UV-induced premalignant and malignant skin tumors in hairless mice. We have modeled this change (9821insA) in murine cybrid cells and demonstrated that this alteration in mtDNA associated with mtBALB haplotype can alter the biochemical characteristics of cybrids and subsequently can contribute to significant changes in their behavioral capabilities. This study shows that changes in mtDNA can produce differences in expression levels of specific nuclear-encoded genes, which are capable of triggering the phenotypes such as seen in malignant cells. From a potential list of differentially expressed genes discovered by microarray analysis, we selected MMP-9 and Col1a1 for further studies. Real-time PCR confirmed up-regulation of MMP-9 and down-regulation of Col1a1 in cybrids harboring the mtDNA associated with the skin tumors. These cybrids also showed significantly increased migration and invasion abilities compared to wild type. The non-specific MMP inhibitor, GM6001, was able to inhibit migratory and invasive abilities of the 9821insA cybrids confirming a critical role of MMPs in cellular motility. Nuclear factor-κB (NF-κB) is a key transcription factor for production of MMPs. An inhibitor of NF-κB activation, Bay 11-7082, was able to inhibit the expression of MMP-9 and ultimately decrease migration and invasion of mutant cybrids containing 9821insA. These studies confirm a role of NF-κB in the regulation of MMP-9 expression and through this regulation modulates the migratory and invasive capabilities of cybrids with mutant mtDNA. Enhanced migration and invasion abilities caused by up-regulated MMP-9 may contribute to the tumorigenic phenotypic characteristics of mutant cybrids. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22705584      PMCID: PMC3418480          DOI: 10.1016/j.yexcr.2012.06.006

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  44 in total

1.  An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells.

Authors:  Giuseppe Gasparre; Luisa Iommarini; Anna Maria Porcelli; Martin Lang; Gian Gaetano Ferri; Ivana Kurelac; Roberta Zuntini; Elisa Mariani; Lucia Fiammetta Pennisi; Ernesto Pasquini; Gianandrea Pasquinelli; Anna Ghelli; Elena Bonora; Claudio Ceccarelli; Michela Rugolo; Nunzio Salfi; Giovanni Romeo; Valerio Carelli
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

2.  ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.

Authors:  Kaori Ishikawa; Keizo Takenaga; Miho Akimoto; Nobuko Koshikawa; Aya Yamaguchi; Hirotake Imanishi; Kazuto Nakada; Yoshio Honma; Jun-Ichi Hayashi
Journal:  Science       Date:  2008-04-03       Impact factor: 47.728

3.  Expression of collagen genes in the cones of skin in the Duroc/Yorkshire porcine model of fibroproliferative scarring.

Authors:  Kathy Q Zhu; Gretchen J Carrougher; Oliver P Couture; Christopher K Tuggle; Nicole S Gibran; Loren H Engrav
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

4.  Gene expression profiling distinguishes between spontaneous and radiation-induced rat mammary carcinomas.

Authors:  Tatsuhiko Imaoka; Satoshi Yamashita; Mayumi Nishimura; Shizuko Kakinuma; Toshikazu Ushijima; Yoshiya Shimada
Journal:  J Radiat Res       Date:  2008-04-16       Impact factor: 2.724

Review 5.  Reactive oxygen species in tumor metastasis.

Authors:  Makiya Nishikawa
Journal:  Cancer Lett       Date:  2008-03-24       Impact factor: 8.679

6.  Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.

Authors:  Johannes A Mayr; David Meierhofer; Franz Zimmermann; Rene Feichtinger; Christian Kögler; Manfred Ratschek; Nikolaus Schmeller; Wolfgang Sperl; Barbara Kofler
Journal:  Clin Cancer Res       Date:  2008-04-15       Impact factor: 12.531

7.  Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.

Authors:  Giuseppe Gasparre; Anna Maria Porcelli; Elena Bonora; Lucia Fiammetta Pennisi; Matteo Toller; Luisa Iommarini; Anna Ghelli; Massimo Moretti; Christine M Betts; Giuseppe Nicola Martinelli; Alberto Rinaldi Ceroni; Francesco Curcio; Valerio Carelli; Michela Rugolo; Giovanni Tallini; Giovanni Romeo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-15       Impact factor: 11.205

Review 8.  Application of mitochondrial genome information in cancer epidemiology.

Authors:  Mukesh Verma; Deepak Kumar
Journal:  Clin Chim Acta       Date:  2007-04-30       Impact factor: 3.786

Review 9.  Energetics, epigenetics, mitochondrial genetics.

Authors:  Douglas C Wallace; Weiwei Fan
Journal:  Mitochondrion       Date:  2009-09-29       Impact factor: 4.160

10.  Lack of complex I is associated with oncocytic thyroid tumours.

Authors:  F A Zimmermann; J A Mayr; D Neureiter; R Feichtinger; B Alinger; N D Jones; W Eder; W Sperl; B Kofler
Journal:  Br J Cancer       Date:  2009-04-07       Impact factor: 7.640

View more
  9 in total

Review 1.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

2.  Perturbation of maize phenylpropanoid metabolism by an AvrE family type III effector from Pantoea stewartii.

Authors:  Jo Ann E Asselin; Jinshan Lin; Alvaro L Perez-Quintero; Irene Gentzel; Doris Majerczak; Stephen O Opiyo; Wanying Zhao; Seung-Mann Paek; Min Gab Kim; David L Coplin; Joshua J Blakeslee; David Mackey
Journal:  Plant Physiol       Date:  2015-01-29       Impact factor: 8.340

3.  Mutations in BALB mitochondrial DNA induce CCL20 up-regulation promoting tumorigenic phenotypes.

Authors:  James Sligh; Jaroslav Janda; Jana Jandova
Journal:  Mutat Res       Date:  2014-11       Impact factor: 2.433

4.  Mitochondria and familial predisposition to breast cancer.

Authors:  Stefania Weigl; Angelo Paradiso; Stefania Tommasi
Journal:  Curr Genomics       Date:  2013-05       Impact factor: 2.236

Review 5.  The role of AKT/mTOR pathway in stress response to UV-irradiation: implication in skin carcinogenesis by regulation of apoptosis, autophagy and senescence.

Authors:  Elwira Strozyk; Dagmar Kulms
Journal:  Int J Mol Sci       Date:  2013-07-24       Impact factor: 5.923

6.  Increased prevalence of malignancy in adult mitochondrial disorders.

Authors:  J Finsterer; E Krexner
Journal:  J Med Life       Date:  2013-12-25

7.  Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPRmt to promote metastasis.

Authors:  T C Kenny; P Hart; M Ragazzi; M Sersinghe; J Chipuk; M A K Sagar; K W Eliceiri; T LaFramboise; S Grandhi; J Santos; A K Riar; L Papa; M D'Aurello; G Manfredi; M G Bonini; D Germain
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

Review 8.  mtDNA, Metastasis, and the Mitochondrial Unfolded Protein Response (UPRmt).

Authors:  Timothy C Kenny; Doris Germain
Journal:  Front Cell Dev Biol       Date:  2017-04-19

9.  Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression.

Authors:  Antonietta Rosella Farina; Andrew Reay Mackay
Journal:  Cancers (Basel)       Date:  2014-01-27       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.